蛋白质组学识别了酒精相关性肝炎患者的补充蛋白质特征
Moyinoluwa Taiwo1, Emily Huang1, Vai Pathak2
1Department of Inflammation and Immunity.
JCI insight
|April 4, 2024
概括
研究人员在血液和肝脏中确定了特定的补充蛋白,可以帮助诊断严重的酒精相关肝炎 (AH). 这些生物标志物还显示出预测患者结果和死亡风险的潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 与酒精相关的肝炎 (AH) 带来了诊断挑战,阻碍了有效的治疗开发.
- 对于用于AH诊断和管理的非侵入性生物标志物有极大需求.
- 补充系统的激活与乙醇诱导的肝损伤有关.
研究的目的:
- 使用蛋白质组分析识别和描述严重AH (sAH) 中的补充蛋白签名.
- 评估AH中已识别的补充蛋白的诊断和预后潜力.
- 研究补充蛋白与疾病严重程度或死亡率之间的关联.
主要方法:
- 对来自SAH,酒精肝硬化 (AC),酒精使用障碍 (AUD) 和健康对照 (HC) 患者的人类肝脏和血清蛋白质组数据的比较分析.
- 在肝脏和血清中补充蛋白水平的量化和表征.
- 统计分析以确定差异丰富的蛋白质及其与临床结果的关联.
主要成果:
- 多重补充蛋白在sAH患者的肝脏和血清中显著受到干扰.
- 一些补充蛋白质,包括集蛋白11和C1q结合蛋白,有效地将sAH与AC,AUD和HC区分开来.
- 较低的MBL相关的血清蛋白酶1和凝血因子II水平独立预测了sAH患者的90天死亡率.
结论:
- 蛋白质组分析揭示了sAH中明显的补充蛋白签名.
- 补充蛋白质代表AH的有希望的非侵入性诊断和预后生物标志物.
- 需要进一步验证,以便将这些生物标志物纳入AH管理的临床实践.
相关概念视频
Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...


